Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Enalto 10mg orodispersible tablets
0403030X0BCABAH
|
Enalto | Escitalopram | Central Nervous System | No data available |
|
Enalto 15mg orodispersible tablets
0403030X0BCACAI
|
Enalto | Escitalopram | Central Nervous System | No data available |
|
Enalto 20mg orodispersible tablets
0403030X0BCADAJ
|
Enalto | Escitalopram | Central Nervous System | No data available |
|
Enalto 5mg orodispersible tablets
0403030X0BCAAAG
|
Enalto | Escitalopram | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.